PRESS RELEASE
30 June 2025

How Employers Can Control Drug Spend And Comply With Fiduciary Duties

BI
Buchanan Ingersoll & Rooney PC

Contributor

With 450 attorneys and government relations professionals across 15 offices, Buchanan Ingersoll & Rooney provides progressive legal, business, regulatory and government relations advice to protect, defend and advance our clients’ businesses. We service a wide range of clients, with deep experience in the finance, energy, healthcare and life sciences industries.
Prescription drug costs continue to rise at unsustainable rates, placing immense financial pressure on employers and plan sponsors.
United States

Prescription drug costs continue to rise at unsustainable rates, placing immense financial pressure on employers and plan sponsors. Please join Buchanan for a CLE presentation, “How Employers Can Control Drug Spend and Comply with Fiduciary Duties.” During this presentation, attendees will gain a comprehensive understanding of the legal and strategic tools available to manage pharmacy benefit costs while fulfilling fiduciary obligations under ERISA and related laws.

In this webinar, Buchanan presenters Dae Lee and Adam Farkas examine recent litigation trends, regulatory developments, and best practices in Pharmacy Benefit Manager (PBM) contracting, transparency, and plan oversight. Whether advising clients or managing benefits in-house, this session will equip attorneys and employers alike with actionable insights to mitigate risk, reduce drug spend, and protect plan assets.

CLICK HERE to view the webinar recording.

Contributor

With 450 attorneys and government relations professionals across 15 offices, Buchanan Ingersoll & Rooney provides progressive legal, business, regulatory and government relations advice to protect, defend and advance our clients’ businesses. We service a wide range of clients, with deep experience in the finance, energy, healthcare and life sciences industries.
See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More